Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
J Immunol ; 206(12): 2862-2874, 2021 06 15.
Artículo en Inglés | MEDLINE | ID: mdl-34099546

RESUMEN

Despite the remarkable initial efficacy of CD19 chimeric Ag receptor T (CAR-T) cell therapy, a high incidence of relapse has been observed. To further increase treatment efficacy and reduce the rate of escape of Ag-negative cells, we need to develop CAR-T cells that target other Ags. Given its restricted expression pattern, CD37 was considered a preferred novel target for immunotherapy in hematopoietic malignancies. Therefore, we designed a CD37-targeting CAR-T (CD37CAR-T) using the single-chain variable fragment of a humanized anti-CD37 Ab, transmembrane and intracellular domains of CD28, and CD3ζ signaling domains. High levels of CD37 expression were confirmed in B cells from human peripheral blood and bone marrow B cell precursors at late developmental stages; by contrast, more limited expression of CD37 was observed in early precursor B cells. Furthermore, we found that human CD37CAR-T cells with longer spacer lengths exhibited high gene transduction efficacy but reduced capacity to proliferate; this may be due to overactivation and fratricide. Spacer length optimization resulted in a modest transduction efficiency together with robust capacity to proliferate. CD37CAR-T cells with optimized spacer length efficiently targeted various CD37+ human tumor cell lines but had no impact on normal leukocytes both in vitro and in vivo. CD37CAR-T cells effectively eradicated Raji cells in xenograft model. Collectively, these results suggested that spacer-optimized CD37CAR-T cells could target CD37-high neoplastic B cells both in vitro and in vivo, with only limited interactions with their normal leukocyte lineages, thereby providing an additional promising therapeutic intervention for patients with B cell malignancies.


Asunto(s)
Antígenos CD19 , Recurrencia Local de Neoplasia , Antígenos CD19/genética , Antígenos de Neoplasias , Antígenos CD28 , Línea Celular Tumoral , Humanos , Linfocitos T/inmunología , Tetraspaninas
2.
Int J Hematol ; 118(2): 221-230, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37129802

RESUMEN

Patient-derived xenograft (PDX) mouse models are useful for deepening our understanding of the biology of malignant lymphoma; however, factors associated with the success of the PDX lymphoma model are largely unknown. We retrospectively analyzed the characteristics of 66 xenotransplantations from 65 patients. In all, 43 (65%) specimens were obtained from patients aged > 60 years, and 42 (64%) specimens were obtained at diagnosis. Specimens were obtained from patients with the following diseases: diffuse large B-cell lymphoma (n = 30), intravascular large B-cell lymphoma (n = 12), follicular lymphoma (n = 8), peripheral T-cell lymphoma (n = 7), mantle cell lymphoma (n = 2), and other (n = 7). The specimens were sourced mainly from bone marrow (n = 31, 47%) and extranodal tumors (n = 13, 20%). Engraftment was successful in 33/66 (50%) xenotransplantations. The median age of patients who provided successful specimens was significantly higher than that for unsuccessful specimens (p = 0.013). Specimens with a high proportion of tumor cells in the graft and those obtained from patients with relapsed/refractory disease showed higher tendencies toward successful engraftment. Taken together, these data suggest that tumor cells with a highly malignant potential might have a high likelihood of engraftment.


Asunto(s)
Linfoma Folicular , Linfoma de Células B Grandes Difuso , Linfoma de Células del Manto , Humanos , Animales , Ratones , Adulto , Estudios Retrospectivos , Linfoma de Células B Grandes Difuso/terapia , Linfoma de Células B Grandes Difuso/patología , Linfoma Folicular/patología , Linfoma de Células del Manto/patología , Linfocitos/patología
3.
Nat Methods ; 5(12): 1011-7, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19054851

RESUMEN

Appropriate resources and expression technology necessary for human proteomics on a whole-proteome scale are being developed. We prepared a foundation for simple and efficient production of human proteins using the versatile Gateway vector system. We generated 33,275 human Gateway entry clones for protein synthesis, developed mRNA expression protocols for them and improved the wheat germ cell-free protein synthesis system. We applied this protein expression system to the in vitro expression of 13,364 human proteins and assessed their biological activity in two functional categories. Of the 75 tested phosphatases, 58 (77%) showed biological activity. Several cytokines containing disulfide bonds were produced in an active form in a nonreducing wheat germ cell-free expression system. We also manufactured protein microarrays by direct printing of unpurified in vitro-synthesized proteins and demonstrated their utility. Our 'human protein factory' infrastructure includes the resources and expression technology for in vitro proteome research.


Asunto(s)
Clonación Molecular/métodos , Genoma Humano/genética , Ingeniería de Proteínas/métodos , Proteoma/genética , Proteoma/metabolismo , Proteínas Recombinantes/metabolismo , Sistema Libre de Células , Humanos
4.
Intern Med ; 60(8): 1271-1277, 2021 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-33162482

RESUMEN

Though adult-onset primary autoimmune pancytopenia (AIP) rarely follows a self-limited course, a standard treatment strategy has not yet been established. We herein report two cases, each involving primary autoimmune neutropenia complicated with autoimmune thrombocytopenia or Evans syndrome. They were refractory to granulocyte-colony stimulating factor, but all lineages of cytopenia promptly recovered with prednisolone (PSL). In case 1, PSL was tapered and discontinued six months after its initiation without AIP relapse. In case 2, PSL has been tapered for five months without relapse. To establish an optimal treatment strategy for AIP, it is necessary to accumulate more cases.


Asunto(s)
Anemia Hemolítica Autoinmune , Enfermedades Autoinmunes , Neutropenia , Trombocitopenia , Adulto , Anemia Hemolítica Autoinmune/complicaciones , Anemia Hemolítica Autoinmune/diagnóstico , Anemia Hemolítica Autoinmune/tratamiento farmacológico , Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/diagnóstico , Enfermedades Autoinmunes/tratamiento farmacológico , Factor Estimulante de Colonias de Granulocitos/uso terapéutico , Humanos , Neutropenia/tratamiento farmacológico , Prednisolona/uso terapéutico , Trombocitopenia/complicaciones , Trombocitopenia/tratamiento farmacológico
5.
Am J Pathol ; 175(6): 2557-65, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19893028

RESUMEN

Inhibition of amyloid-beta (Abeta) aggregation is an attractive therapeutic strategy for Alzheimer's disease (AD). Certain phenolic compounds have been reported to have anti-Abeta aggregation effects in vitro. This study systematically investigated the effects of phenolic compounds on AD model transgenic mice (Tg2576). Mice were fed five phenolic compounds (curcumin, ferulic acid, myricetin, nordihydroguaiaretic acid (NDGA), and rosmarinic acid (RA)) for 10 months from the age of 5 months. Immunohistochemically, in both the NDGA- and RA-treated groups, Abeta deposition was significantly decreased in the brain (P < 0.05). In the RA-treated group, the level of Tris-buffered saline (TBS)-soluble Abeta monomers was increased (P < 0.01), whereas that of oligomers, as probed with the A11 antibody (A11-positive oligomers), was decreased (P < 0.001). However, in the NDGA-treated group, the abundance of A11-positive oligomers was increased (P < 0.05) without any change in the levels of TBS-soluble or TBS-insoluble Abeta. In the curcumin- and myricetin-treated groups, changes in the Abeta profile were similar to those in the RA-treated group, but Abeta plaque deposition was not significantly decreased. In the ferulic acid-treated group, there was no significant difference in the Abeta profile. These results showed that oral administration of phenolic compounds prevented the development of AD pathology by affecting different Abeta aggregation pathways in vivo. Clinical trials with these compounds are necessary to confirm the anti-AD effects and safety in humans.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Péptidos beta-Amiloides/efectos de los fármacos , Fenoles/farmacología , Transducción de Señal/efectos de los fármacos , Enfermedad de Alzheimer/patología , Péptidos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/genética , Animales , Cinamatos/farmacología , Ácidos Cumáricos/farmacología , Curcumina/farmacología , Depsidos/farmacología , Modelos Animales de Enfermedad , Femenino , Flavonoides/farmacología , Humanos , Inmunohistoquímica , Masoprocol/farmacología , Ratones , Ratones Transgénicos , Ácido Rosmarínico
6.
Appl Spectrosc ; 61(3): 269-75, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17389066

RESUMEN

Attenuated total reflection surface-enhanced infrared absorption microspectroscopy (micro-ATR-SEIRA) was developed for the identification of sub-mm size and nm-thick layers on material surfaces by using gold island films deposited on the surface of micro-ATR crystals. A thin layer of triphenyl phosphate (TPP) on a poly(tetrafluoroethylene) (PTFE) membrane filter was used to evaluate the enhancement of the absorption bands. Three types of crystals: diamond, silicon, and germanium, were evaluated. Diamond gave the greatest enhancement with a 12 nm thick gold island film. The enhancement factor was 200 times compared to bare diamond crystal, whereas it was 10 times for germanium crystal. This variation of enhancement factor according to crystal types was presumed to be due to the morphology of the gold films on the crystals. We also obtained an enhanced ATR map over an area of approximately 2 x 6 mm for a thin layer (approximately 1 nm thick) of di-2-ethylhexylphthalate on PTFE using gold-coated hexagonal silicon micro-ATR crystals. This micro-ATR-SEIRA technique has major potential for analyzing small and thin substances on material surfaces.

7.
Intern Med ; 56(4): 435-439, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28202867

RESUMEN

Pulmonary alveolar proteinosis (PAP) is classified as autoimmune, secondary, or genetic. We herein describe a 69-year-old man with autoimmune PAP, simultaneously diagnosed with myeloproliferative neoplasm (MPN). Two years after the diagnosis, the MPN progressed to acute myeloid leukemia, and the patient died from an alveolar hemorrhage during remission induction chemotherapy. Throughout the clinical course, no progression of PAP was observed, despite the progression to leukemia. There are few reports of autoimmune PAP with hematological malignancy, and this case demonstrated that an evaluation for GM-CSF autoantibodies is important for distinguishing the autoimmune and secondary forms of PAP, even if the patient has hematological malignancy.


Asunto(s)
Autoanticuerpos/sangre , Enfermedades Autoinmunes/diagnóstico , Factor Estimulante de Colonias de Granulocitos y Macrófagos/inmunología , Trastornos Mieloproliferativos/etiología , Proteinosis Alveolar Pulmonar/diagnóstico , Anciano , Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/patología , Biopsia , Progresión de la Enfermedad , Resultado Fatal , Humanos , Leucemia Mieloide Aguda/etiología , Pulmón/patología , Masculino , Proteinosis Alveolar Pulmonar/complicaciones , Proteinosis Alveolar Pulmonar/patología , Radiografía Torácica , Tomografía Computarizada por Rayos X
8.
J Clin Exp Hematop ; 57(2): 74-78, 2017 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-28883221

RESUMEN

Herein, we describe a 61-year-old man diagnosed with pulmonary hemosiderosis following chemotherapy for acute adult T-cell leukemia/lymphoma (ATLL). Liver and heart biopsy confirmed hemosiderosis. ATLL progressed, and the patient died from multiorgan damage. Welder's lung may have been involved in hemosiderosis and systemic iron overload. Abnormal iron metabolism or immune reactions may have influenced the clinical course, but these were not validated. Detailed analyses of family medical and lifestyle histories, and genetic examination should be performed in cases of systemic iron overload.


Asunto(s)
Hemosiderosis , Sobrecarga de Hierro , Leucemia-Linfoma de Células T del Adulto , Enfermedades Pulmonares , Enfermedad Aguda , Hemosiderosis/complicaciones , Hemosiderosis/diagnóstico , Hemosiderosis/patología , Humanos , Sobrecarga de Hierro/complicaciones , Sobrecarga de Hierro/diagnóstico , Sobrecarga de Hierro/patología , Leucemia-Linfoma de Células T del Adulto/patología , Leucemia-Linfoma de Células T del Adulto/terapia , Enfermedades Pulmonares/complicaciones , Enfermedades Pulmonares/diagnóstico , Enfermedades Pulmonares/patología , Masculino , Persona de Mediana Edad , Hemosiderosis Pulmonar
9.
J Chromatogr A ; 1132(1-2): 256-9, 2006 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-16901495

RESUMEN

A novel apparatus with a simple structure has been developed for introducing samples into the vaporizing chamber of a gas chromatograph. It requires no septum due to the gas sealing structure over the carrier gas supply line. The septum-free injector made it possible to use injection port temperatures as high as 450 degrees C. Repetitive injection of samples with boiling points below 300 degrees C resulted in peak areas with relative standard deviations between 1.25 and 3.28% (n=5) and good linearity (r(2)>0.9942) for the calibration curve. In the analysis of polycyclic aromatic hydrocarbons and a base oil, the peak areas of components with high boiling points increased as the injection port temperature was increased to 450 degrees C.


Asunto(s)
Cromatografía de Gases/instrumentación , Cromatografía de Gases/métodos , Calibración , Hidrocarburos Policíclicos Aromáticos/análisis , Hidrocarburos Policíclicos Aromáticos/química , Temperatura de Transición
10.
Anal Sci ; 20(12): 1623-8, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15636505

RESUMEN

Molecular ions include information about end groups, functional groups and molecular weight. A method for the direct detection of these in the high mass range (m/z > 1000) from poly(dimethylsiloxane) (PDMS) on a solid surface was investigated. It was found that a TOF-SIMS analysis of silver-deposited surfaces (silver deposition/TOF-SIMS) is useful for this purpose. Using the silver-deposition/TOF-SIMS method, silver-cationized quasi-molecular ions were clearly detected from PDMS on solid surfaces, and their structure and molecular weight were evaluated. In addition, their images were observed without the interference of deposited silver. By applying to the analysis of paint defects etc., it was confirmed that this technique is useful to analyze actual industrial materials. Silver-cationized ions were detected not only from PDMS, but also from other organic materials, such as lubricant additives and oils on solid surfaces. Therefore, the silver deposition/TOF-SIMS method was proved to be useful for the analysis of ultrathin substances on solid surfaces.

11.
Glycobiology ; 16(8): 702-10, 2006 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16624895

RESUMEN

Keratan sulfate (KS) is a glycosaminoglycan composed of repeating disaccharide units with sulfate residues at the C6 positions of galactose and N-acetylglucosamine (GlcNAc). The N-acetylglucosamine 6-O-sulfotransferase(s) (GlcNAc6ST) involved in the synthesis of KS in the central nervous system (CNS) has long been unidentified. Here, we report that a deficiency of GlcNAc6ST-1 leads to loss of 5D4-reactive brain KS and reduction of glial scar formation after cortical stab injury in mice. During the development of mice deficient in GlcNAc6ST-1, KS expression in the brain was barely detectable with the KS-specific antibody 5D4. The reactivity of 5D4 antibody with protein tyrosine phosphatase zeta (PTPzeta), a KS proteoglycan (KSPG), was abolished in the deficient mice. In adults, brain injury induced 5D4-reactive KS synthesis in the wounded area in wild-type (WT) mice but not in the deficient mice. Glial scar is formed via the accumulation of reactive astrocytes and is a major obstacle to axonal regeneration by injured neurons. Reactive astrocytes appeared to similar extents in the two genotypes, but they accumulated in the wounded area to a lesser extent in the deficient mice. Consequently, the deficient mice exhibited a marked reduction of scarring and enhanced neuronal regeneration after brain injury. These findings highlight the indispensable role of GlcNAc6ST-1 in brain KS biosynthesis and glial scar formation after brain injury.


Asunto(s)
Astrocitos/patología , Lesiones Encefálicas/patología , Lesiones Encefálicas/fisiopatología , Sulfato de Queratano/biosíntesis , Sulfotransferasas/genética , Sulfotransferasas/metabolismo , Acetilglucosamina/química , Animales , Lesiones Encefálicas/etiología , Colágeno Tipo IV/análisis , Colágeno Tipo IV/metabolismo , Proteína Ácida Fibrilar de la Glía/análisis , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica , Sulfato de Queratano/química , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Sulfotransferasas/química , Sulfotransferasas/deficiencia , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA